Sigma Healthcare Limited (ASX: SIG)
Australia
· Delayed Price · Currency is AUD
2.780
-0.070 (-2.46%)
Jan 21, 2025, 4:10 PM AEST
Sigma Healthcare Revenue
Sigma Healthcare had revenue of 1.84B AUD in the half year ending July 31, 2024, with 0.23% growth. This brings the company's revenue in the last twelve months to 3.48B, down -0.72% year-over-year. In the fiscal year ending January 31, 2024, Sigma Healthcare had annual revenue of 3.32B, down -9.24%.
Revenue (ttm)
3.48B
Revenue Growth
-0.72%
P/S Ratio
1.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 3.32B | -338.18M | -9.24% |
Jan 31, 2023 | 3.66B | 214.08M | 6.21% |
Jan 31, 2022 | 3.45B | 45.79M | 1.35% |
Jan 31, 2021 | 3.40B | 156.12M | 4.81% |
Jan 31, 2020 | 3.24B | -732.51M | -18.42% |
Jan 31, 2019 | Pro | Pro | Pro |
Jan 31, 2018 | Pro | Pro | Pro |
Jan 31, 2017 | Pro | Pro | Pro |
Jan 31, 2016 | Pro | Pro | Pro |
Jan 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
Pro Medicus | 161.50M |
Cochlear | 2.24B |
Sonic Healthcare | 8.97B |
Telix Pharmaceuticals | 645.68M |
Ramsay Health Care | 16.66B |
Ansell | 2.43B |
Mesoblast | 8.85M |
Sigma Healthcare News
- 2 months ago - Sigma Rallies to 17-Year High on Chemist Warehouse Deal Approval - BNN Bloomberg
- 3 months ago - Pharmacy lobby says Chemist Warehouse concessions are ‘tokenistic’ - The Australian Financial Review
- 4 months ago - Sigma Healthcare Ltd (SIGGF) (Q2 2025) Earnings Call Transcript Highlights: Strong Revenue ... - GuruFocus
- 4 months ago - Half Year 2025 Sigma Healthcare Ltd Earnings Call Transcript - GuruFocus
- 5 months ago - Competition regulator delays $8.8b Chemist Warehouse deal approval - The Australian Financial Review